CMS proposes new billing policy for Medicare providers

Check out these important FDA updates from the month of July 2024.

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

The approval of eculizumab-aagh offers more treatment options for patients with rare diseases PNH and aHUS.

The approval offers a first of its kind treatment option for patients living with nonerosive GERD.

The companies are marketing products that may violate Federal Trade Commission prohibition of “unfair and deceptive acts in the marketplace.”

Had Novo Nordisk’s insulin icodec secured FDA approval, it would have been the first and only once-weekly basal insulin option for adults with diabetes.